Manufacturer of Controlled Substances; Notice of Application, 65135 [E6-18714]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 215 / Tuesday, November 7, 2006 / Notices
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a) and determined
that the registration of Mallinckrodt
Inc., to import the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated Mallinckrodt Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: October 31, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–18716 Filed 11–6–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on June 26, 2006, and
August 17, 2006, Siegfried (USA), Inc.,
Industrial Park Road, Pennsville, New
Jersey 08070, made application by letter
to the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Schedule
ycherry on PROD1PC64 with NOTICES
Dihydromorphine (9145) ...............
Oxymorphone (9652) ...................
I
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such substances
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
VerDate Aug<31>2005
14:44 Nov 06, 2006
Jkt 211001
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than January 8, 2007.
Dated: October 31, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–18714 Filed 11–6–06; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
National Endowment for the
Humanities; No Fear Act Notice
National Endowment for the
Humanities, National Foundation on the
Arts and the Humanities.
ACTION: Notice.
AGENCY:
SUMMARY: The National Endowment for
the Humanities (NEH) is publishing this
notice under the ‘‘Notification and
Federal Employee Antidiscrimination
and Retaliation Act of 2002,’’ which is
known as the No FEAR Act, to inform
current employees, former employees,
and applicants for NEH employment of
the rights and protections available to
them under Federal antidiscrimination,
whistleblower protection and retaliation
laws.
FOR FURTHER INFORMATION CONTACT:
Heather C. Gottry, Acting General
Counsel, Office of General Counsel,
NEH, 1100 Pennsylvania Ave., NW.,
Room 529, Washington, DC 20506; OGC
Internet E-mail: gencounsel@neh.gov
(for E-mail messages, the subject line
should include the following
reference—‘‘No FEAR Act Notice’’);
Telephone: (202) 606–8322; TDD (202)
606–8282; Fax: (202) 606–8600. A copy
of the No FEAR Act Notice will be
posted on NEH’s Web site (https://
www.neh.gov). Persons who cannot
access this No FEAR Act Notice through
the Internet may request a paper or
electronic copy by contacting Ms. Gottry
at the address, e-mail address, telephone
numbers, or Fax number listed above.
SUPPLEMENTARY INFORMATION: On May
15, 2002, Congress enacted the
‘‘Notification and Federal Employee
Antidiscrimination and Retaliation Act
of 2002,’’ which is now known as the
No FEAR Act. One purpose of the Act
is to require that Federal agencies be
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
65135
accountable for violations of
antidiscrimination and whistleblower
protection laws. In support of this
purpose, Congress found that ‘‘agencies
cannot be run effectively if those
agencies practice or tolerate
discrimination.’’ Public Law 107–174,
Section 101(1), 116 Stat. 566. The Act
also requires this Agency to provide this
notice to Federal employees, former
Federal employees and applicants for
Federal employment to inform them of
the rights and protections available to
them under Federal antidiscrimination,
whistleblower protection, and
retaliation laws.
Antidiscrimination Laws
A Federal agency cannot discriminate
against an employee or applicant with
respect to the terms, conditions or
privileges of employment on the basis of
race, color, religion, sex, national origin,
age, disability, marital status or political
affiliation. Discrimination on these
bases is prohibited by one or more of the
following statutes: 5 U.S.C. 2302(b)(1),
29 U.S.C. 206(d), 29 U.S.C. 631, 29
U.S.C. 633a, 29 U.S.C. 791, and 42
U.S.C. 2000e–16.
If you believe that you have been the
victim of unlawful discrimination on
the basis of race, color, religion, sex,
national origin or disability, you must
contact an Equal Employment
Opportunity (EEO) counselor within 45
calendar days of the alleged
discriminatory action, or, in the case of
a personnel action, within 45 calendar
days of the effective date of the action,
before you can file a formal complaint
of discrimination with your agency. See,
e.g. 29 CFR part 1614. If you believe that
you have been the victim of unlawful
discrimination on the basis of age, you
must either contact an EEO counselor as
noted above or give notice of intent to
sue to the Equal Employment
Opportunity Commission (EEOC) within
180 calendar days of the alleged
discriminatory action. If you are alleging
discrimination based on marital status
or political affiliation, you may file a
written complaint with the U.S. Office
of Special Counsel (OSC) (see contact
information below). In the alternative
(or in some cases, in addition), you may
pursue a discrimination complaint by
filing a grievance through your agency’s
administrative or negotiated grievance
procedures, if such procedures apply
and are available.
Whistleblower Protection Laws
A Federal employee with authority to
take, direct others to take, recommend
or approve any personnel action must
not use that authority to take or fail to
take, or threaten to take or fail to take,
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 71, Number 215 (Tuesday, November 7, 2006)]
[Notices]
[Page 65135]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-18714]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on June 26, 2006, and August 17,
2006, Siegfried (USA), Inc., Industrial Park Road, Pennsville, New
Jersey 08070, made application by letter to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Dihydromorphine (9145)..................... I
Oxymorphone (9652)......................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration pursuant to 21 CFR
1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative/ODL; or any being sent via express mail should be sent
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must
be filed no later than January 8, 2007.
Dated: October 31, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-18714 Filed 11-6-06; 8:45 am]
BILLING CODE 4410-09-P
